Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population

AIM: Multigene panel testing for Hereditary Breast and Ovarian Cancer (HBOC) using next generation sequencing is becoming more common in medical care. We report our experience regarding deleterious mutations of high and moderate-risk breast cancer genes (BRCA1/2, TP53, STK11, CDH1, PTEN, PALB2, CHEK...

Descripción completa

Detalles Bibliográficos
Autores principales: GOIDESCU, IULIAN GABRIEL, CARACOSTEA, GABRIELA, ENIU, DAN TUDOR, STAMATIAN, FLORIN VASILE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958980/
https://www.ncbi.nlm.nih.gov/pubmed/29785153
http://dx.doi.org/10.15386/cjmed-894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958980/
https://www.ncbi.nlm.nih.gov/pubmed/29785153
http://dx.doi.org/10.15386/cjmed-894

Ejemplares similares